BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 27/01/1999

FDA Announces Pilot Program for Gamma Irradiated Blood and Blood Components

The FDA is launching a pilot program to allow licensed blood product manufacturers to market irradiated blood components across state lines, and is seeking public comment on a draft guidance document outlining the program's criteria and procedures.

Source: Federal Register — Food and Drug AdministrationOpen original release →